Aspen Grove Capital, LLC

Position in AMGN — Amgen Inc

CIK 1806027 AVON, CO

Position in AMGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,045,802

+$29,660 QoQ

Shares Held

2,888

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,677

of 3,140 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aspen Grove Capital, LLC holds $11,919,703 across 10 Drug Manufacturers - General names. AMGN ranks #4 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,303	$5,161,147
2	PFE	Pfizer Inc	63,351	$1,525,492
3	GSK	GSK plc	23,082	$1,209,958
4	AMGN	Amgen Inc This page	2,888	$1,045,802
5	JNJ	Johnson & Johnson	3,238	$822,354
6	ABBV	AbbVie Inc.	2,252	$566,693
7	MRK	Merck & Co., Inc.	3,683	$473,265
8	AZN	Astrazeneca PLC	2,371	$449,589

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,045,802	2,888	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,016,142	2,888	0.0%	Shares	Sole	2026-05-14
2025-12-31	$945,271	2,888	+0.3%	Shares	Sole	2026-02-17
2025-09-30	$812,736	2,880	-3.5%	Shares	Sole	2025-11-14
2025-06-30	$833,162	2,984	+9.7%	Shares	Sole	2025-08-14
2025-03-31	$847,104	2,719	+4.1%	Shares	Sole	2025-05-14
2024-12-31	$681,052	2,613	-1.1%	Shares	Sole	2025-02-14
2024-09-30	$851,278	2,642	0.0%	Shares	Sole	2024-11-13
2024-06-30	$825,492	2,642	+0.6%	Shares	Sole	2024-08-14
2024-03-31	$746,624	2,626	+0.4%	Shares	Sole	2024-05-15
2023-12-31	$753,172	2,615	+3.4%	Shares	Sole	2024-02-14
2023-09-30	$679,425	2,528	+3.8%	Shares	Sole	2023-11-13
2023-06-30	$540,618	2,435	-5.3%	Shares	Sole	2023-08-14
2023-03-31	$621,539	2,571	+2.3%	Shares	Sole	2023-05-15
2022-12-31	$660,276	2,514	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.